Portfolio Alerts Watch List Cart

Healthcare

Refine Search


Product Compare (0)
A
Ambey Laboratories Ltd
Score 48/100• Risky
Ambey Laboratories Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health77/100
Valuation 80/100 · PB 1.307
Technical Avoid
1M 6.667% 6M -1.84% 1Y -43.543%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEThin margins
#271
View details ➜
A
Amanta Healthcare Ltd
Score 48/100• Risky
Amanta Healthcare Ltd presents a risky investment opportunity due to inconsistent growth and valuation concerns.
Company’s Health58/100
Valuation 40/100 · PB 3.8062
Technical Avoid
1M -14.749% 6M -25.503% 1Y -25.503%
Confidence100%
No promoter pledge
Weak ROEHigh debt/equity
#272
View details ➜
A
Adeshwar Meditex Ltd
Score 48/100• Risky
Adeshwar Meditex Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health64/100
Valuation 100/100 · PB 0.6634
Technical Avoid
1M 4.492% 6M -6.904% 1Y -26.13%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#273
View details ➜
A
Amwill Health Care Ltd
Score 48/100• Risky
Amwill Health Care Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
Company’s Health98/100
Valuation 80/100 · PB 1.0847
Technical Avoid
1M -25.415% 6M -46.667% 1Y -59.678%
Confidence100%
Low leverage (D/E)No promoter pledge
#274
View details ➜
A
Alivus Life Sciences Ltd
Score 48/100• Risky
Alivus Life Sciences Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health93/100
Valuation 40/100 · PB 3.8696
Technical Avoid
1M -3.143% 6M -13.623% 1Y -14.252%
Confidence100%
Low leverage (D/E)No promoter pledge
#275
View details ➜
A
Albert David Ltd
Score 48/100• Decent
While Albert David Ltd operates in a promising sector, its inconsistent growth and valuation concerns suggest caution for investors.
Company’s Health66/100
Valuation 80/100 · PB 1.1201
Technical Avoid
1M -12.059% 6M -10.493% 1Y -46.537%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#276
View details ➜
G
Godavari Drugs Ltd
Score 48/100• Risky
Godavari Drugs Ltd presents several risks with inconsistent growth and weak market sentiment, making it a risky investment at this time.
Company’s Health52/100
Valuation 80/100 · PB 1.2401
Technical Avoid
1M -8.276% 6M -24.723% 1Y -42.191%
Confidence100%
Reasonable PB valuation
Weak ROEPromoter pledge present
#277
View details ➜
G
Global Longlife Hospital and Research Ltd
Score 48/100• Risky
The stock presents several risks with limited growth potential and profitability concerns, making it a risky investment.
Company’s Health50/100
Valuation 100/100 · PB 0.8223
Technical Avoid
1M -16.025% 6M -20.258% 1Y -32.469%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#278
View details ➜
G
Glenmark Pharmaceuticals Ltd
Score 48/100• Risky
Glenmark Pharmaceuticals presents several risks with inconsistent growth and profitability metrics, alongside governance concerns. Caution is advised for potential investors.
Company’s Health63/100
Valuation 20/100 · PB 6.2984
Technical Watch
1M 7.846% 6M 20.456% 1Y 28.66%
Confidence100%
Low leverage (D/E)No promoter pledge
Thin margins
#279
View details ➜
G
GKB Ophthalmics Ltd
Score 48/100• Risky
GKB Ophthalmics Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in financial performance.
Company’s Health60/100
Valuation 100/100 · PB 0.4506
Technical Avoid
1M -13.739% 6M -34.819% 1Y -49.771%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#280
View details ➜
G
Gennex Laboratories Ltd
Score 48/100• Risky
Gennex Laboratories Ltd shows potential but faces significant risks and inconsistencies in growth and profitability.
Company’s Health59/100
Valuation 80/100 · PB 1.6356
Technical Avoid
1M -16.656% 6M 0.153% 1Y -27.141%
Confidence100%
Low leverage (D/E)Healthy profit margins
Weak ROEPromoter pledge present
#281
View details ➜
G
Ganga Pharmaceuticals Ltd
Score 48/100• Risky
Ganga Pharmaceuticals Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
Company’s Health48/100
Valuation 100/100 · PB 0.9684
Technical Avoid
1M 0% 6M -21.081% 1Y -35.111%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#282
View details ➜
E
Eris Lifesciences Ltd
Score 48/100• Decent
Eris Lifesciences Ltd shows decent potential with consistent growth and profitability metrics, but faces challenges in valuation and execution risks.
Company’s Health69/100
Valuation 20/100 · PB 6.5457
Technical Avoid
1M -0.025% 6M -12.222% 1Y 3.92%
Confidence100%
Healthy profit marginsDecent revenue growth
Weak ROEPromoter pledge present
#283
View details ➜
E
Emmessar Biotech and Nutrition Ltd
Score 48/100• Risky
Emmessar Biotech and Nutrition Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health68/100
Valuation 80/100 · PB 1.8986
Technical Avoid
1M -2.806% 6M -10.969% 1Y -35.83%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#284
View details ➜
E
Eiko Lifesciences Ltd
Score 48/100• Risky
Eiko Lifesciences Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health84/100
Valuation 80/100 · PB 1.309
Technical Avoid
1M -2.358% 6M 7.367% 1Y -11.455%
Confidence100%
Low leverage (D/E)No promoter pledge
Thin margins
#285
View details ➜
Showing 271 to 285 of 301 (21 Pages)